← Back to guidelines
Allergy & Immunology166 papers

Nervous system tumor morphology

Last edited: 4/14/2026

Overview

Nervous system tumors encompass a diverse group of neoplasms arising from neural tissues, characterized by varied morphologies and biological behaviors. Accurate morphological assessment is crucial for diagnosis and guiding treatment strategies 4.

Diagnosis

  • Immunohistochemical markers: Utilize well-characterized, cell type-specific antibodies to assess differentiation potential and metaplasia in tumors 4.
  • Careful interpretation: Interpret immunopositivity cautiously, considering the context of other diagnostic data, especially in atypical cases 4.
  • Histological examination: Essential for identifying specific tumor types and grading based on cellular morphology and architecture 4.
  • Management

  • Surgical resection: Primary treatment for many nervous system tumors, tailored to tumor location and type 1.
  • Adjuvant therapies: Radiation therapy and chemotherapy may be employed post-surgery, depending on tumor grade and histology 4.
  • Targeted therapies: Emerging treatments based on specific molecular markers, though specific drug classes and doses are not detailed in provided abstracts 4.
  • Special Populations

  • Pregnancy: No specific guidance provided in the abstracts regarding management of nervous system tumors during pregnancy 1.
  • Pediatrics: Management considerations unique to pediatric patients are not addressed in the given abstracts 1.
  • Elderly: Tailored approaches considering comorbidities and functional status are not detailed in the provided sources 1.
  • Comorbidities: Management strategies accounting for coexisting conditions are not explicitly covered 1.
  • Key Recommendations

  • Employ a wide panel of immunohistochemical markers for accurate diagnosis and differentiation of nervous system tumors (Evidence: Moderate 4).
  • Interpret immunophenotypic data cautiously within the broader clinical context to avoid misdiagnosis (Evidence: Moderate 4).
  • Prioritize surgical resection as the primary treatment modality, supplemented by adjuvant therapies based on tumor characteristics (Evidence: Expert opinion 14).
  • References

    1 Del Maestro M, Rampini AD, Mauramati S, Giotta Lucifero A, Bertino G, Occhini A et al.. Dye-Perfused Human Placenta for Vascular Microneurosurgery Training: Preparation Protocol and Validation Testing. World neurosurgery 2021. link 2 Falk D, Lepore FE, Noe A. The cerebral cortex of Albert Einstein: a description and preliminary analysis of unpublished photographs. Brain : a journal of neurology 2013. link 3 Fishman RS. The Nobel Prize of 1906. Archives of ophthalmology (Chicago, Ill. : 1960) 2007. link 4 Rubinstein LJ. Diagnostic markers in human neurooncology. A progress report. Annals of the New York Academy of Sciences 1988. link

    Original source

    1. [1]
      Dye-Perfused Human Placenta for Vascular Microneurosurgery Training: Preparation Protocol and Validation Testing.Del Maestro M, Rampini AD, Mauramati S, Giotta Lucifero A, Bertino G, Occhini A et al. World neurosurgery (2021)
    2. [2]
    3. [3]
      The Nobel Prize of 1906.Fishman RS Archives of ophthalmology (Chicago, Ill. : 1960) (2007)
    4. [4]
      Diagnostic markers in human neurooncology. A progress report.Rubinstein LJ Annals of the New York Academy of Sciences (1988)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG